Warren Buffett Has Beaten the Market Over a 60-Year Stretch. Here Are 3 of the Billionaire's Favorite Stocks Warren Buffett officially handed the CEO keys to Greg Abel at the end of 2025, but the Oracle of Omaha remains Berkshire Hathaway's (NYSE: BRKA)(NYSE: BRKB)
Quick Read - UnitedHealth Group (UNH) reported Q1 EPS beat +9.38%, bouncing 31.24% in one month, but full-year 2025 operating income collapsed 41.26%, net income fell 16.31%, lost 965,000 Medicare Advantage members in Q1, and faces CMS rate-flat proposals for 2027 that threaten...</strong
Key Points - Lucid Diagnostics reported Q1 2026 EsoGuard test volume of 3,177 and revenue of $1.3 million, with volume still above its pre-Medicare target range despite a sequential decline from Q4. - Management said the company remains highly focused on a Medicare local... <
Key Points - Chicago Atlantic BDC posted record first-quarter 2026 net investment income of $10 million, or $0.44 per share, and kept its quarterly dividend at $0.34 for the seventh straight quarter. - The company said portfolio growth accelerated, with $93.9 million funded...</p
Key Points - Kyivstar delivered strong Q1 growth, with revenue up nearly 27% year over year to $323 million and EBITDA rising more than 23% to $173 million. Equity free cash flow also increased almost 32% to $87 million, showing continued cash generation despite wartime op
Key Points - Key clinical catalysts are ahead for Karyopharm, including FDA engagement and publication plans for its Phase 3 SENTRY myelofibrosis trial, plus an expected mid-2026 readout from the endometrial cancer study XPORT-EC-042. - The SENTRY trial showed a statistically...<
Key Points - Kolibri Global Energy posted what management called its strongest quarter ever, with record first-quarter production of 4,685 BOE/day, net revenue of $19.6 million, and adjusted EBITDA of $14.8 million. - The company continued to strengthen its balance sheet:...
Key Points - Q1 earnings weakened as net investment income fell to $0.38 per share from $0.45, while NAV dropped to $18.27 from $19.10. Management said higher non-accruals, lower base rates, and credit-market volatility were the main pressures. - Crescent raised its non-ac
Cerebras (CBRS) IPO started trading at $385. The IPO price was set at $185 raising $5.5B at the IPO price Investor in at the IPO price are already up 108.11%. Cerebras is an AI chip designer that competes with Nvidia, known for its Wafer-Scale Engine (WSE) — a singl
SUNS management highlights opportunities in 2021-2022 vintage bridge loans amid sector bifurcation and capital recycling. Sunrise Realty Trust reported Q1 2026 performance driven by capital recycling, including a Colorado bridge loan and Dallas multifamily payoff. The firm
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.